Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 2,175.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 3,950.00p
  • 52 Week Low: 1,835.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 9,888
  • Market Cap: £113.64m
  • Beta: 0.30

Deal with Barclays    Trade now with Barclays Stockbrokers

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 6.9% 0.0%
Div Cover 1.0 0.9
Op Mrgn 75.5% 75.2%
ROCE 77.0%  
Latest F'cast
P/E 15.0 16.0
PEG n/a n/a
Pr/Revenue 8.7 9.1
Pr/Book 9.8  
Latest F'cast
Revenue -3.6% -4.7%
PBT -4.8% -6.9%
EPS -6.3% -6.3%
DPS -3.2% n/a

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%
30-Jun-25 13.12 10.10 145.27p 18.9 n/a -6% 150.00p 5.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 12.50 9.40 136.10p 16.0 n/a -6% 150.00p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Director Dealing 04-Nov-2025 16:12 RNS
Director Dealing 30-Oct-2025 07:00 RNS
Director Dealing 27-Oct-2025 15:53 RNS

Bioventix ShareCast News

China weakness sees profits fall for Bioventix 27-Oct-2025 ShareCast
Revenue rises, profit falls for Bioventix 31-Mar-2025 ShareCast
Director dealings: Bioventix CFO raises stake 31-Oct-2024 ShareCast

Latest Bioventix Director Deals

Traded Action Notifier PriceAmountValue
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
29-Oct-25 Buy Ian James Nicholson 1,865.00p 500 £9,325.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,175.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 3,950.00p
52 Week Low 1,835.00p
Volume 9,888
Shares Issued 5.22m
Market Cap £113.64m
Beta 0.30

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 04-Nov-2025

Time Volume / Share Price
15:47 500 @ 2,121.00p
15:30 30 @ 2,121.00p
15:25 50 @ 2,194.00p
15:19 90 @ 2,121.00p
15:18 2 @ 2,100.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page